Search Results - "Portela Catani, João Paulo"
-
1
Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
Published in Immunity (Cambridge, Mass.) (18-04-2013)“…The therapeutic efficacy of anthracyclines relies on antitumor immune responses elicited by dying cancer cells. How chemotherapy-induced cell death leads to…”
Get full text
Journal Article -
2
Anti-neuraminidase and anti-hemagglutinin immune serum can confer inter-lineage cross protection against recent influenza B
Published in PloS one (23-01-2023)“…Influenza B viruses (IBV) are responsible for a considerable part of the burden caused by influenza virus infections. Since their emergence in the 1980s, the…”
Get full text
Journal Article -
3
The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017
Published in eLife (28-05-2024)“…Human H3N2 influenza viruses are subject to rapid antigenic evolution which translates into frequent updates of the composition of seasonal influenza vaccines…”
Get full text
Journal Article -
4
Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy
Published in Cancer Immunology, Immunotherapy (01-04-2016)“…Previously, we combined p19 Arf ( Cdkn2a , tumor suppressor protein) and interferon beta (IFN-β, immunomodulatory cytokine) gene transfer in order to enhance…”
Get full text
Journal Article -
5
Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase
Published in npj vaccines (27-01-2022)“…The neuraminidase (NA) is an abundant antigen at the surface of influenza virions. Recent studies have highlighted the immune-protective potential of NA…”
Get full text
Journal Article -
6
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models
Published in Science translational medicine (24-11-2021)“…Broadly neutralizing antibodies are an important treatment for individuals with coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome…”
Get more information
Journal Article -
7
Immunogenicity and Protection Efficacy of a Naked Self-Replicating mRNA-Based Zika Virus Vaccine
Published in Vaccines (Basel) (23-08-2019)“…To combat emerging infectious diseases like Zika virus (ZIKV), synthetic messenger RNAs (mRNAs) encoding viral antigens are very attractive as they allow a…”
Get full text
Journal Article -
8
Corticosteroids and cellulose purification improve, respectively, the in vivo translation and vaccination efficacy of sa-mRNAs
Published in Molecular therapy (07-04-2021)“…Synthetic mRNAs are an appealing platform with multiple biomedical applications ranging from protein replacement therapy to vaccination. In comparison with…”
Get full text
Journal Article -
9
CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy
Published in Cancer research (Chicago, Ill.) (15-01-2014)“…The therapeutic efficacy of anthracyclines relies, at least partially, on the induction of a dendritic cell- and T-lymphocyte-dependent anticancer immune…”
Get full text
Journal Article -
10
ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy
Published in Oncoimmunology (01-06-2013)“…Tumor cells succumb to chemotherapy while releasing ATP. We have found that extracellular ATP attracts dendritic cell (DC) precursors into the tumor bed,…”
Get full text
Journal Article -
11
Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma
Published in Translational oncology (01-12-2016)“…Abstract Therapeutic strategies that act by eliciting and enhancing antitumor immunity have been clinically validated as an effective treatment modality but…”
Get full text
Journal Article -
12
Near future of tumor immunology: Anticipating resistance mechanisms to immunotherapies, a big challenge for clinical trials
Published in Human vaccines & immunotherapeutics (04-05-2017)“…The success of immunotherapies brings hope for the future of cancer treatment. Even so, we are faced with a new challenge, that of understanding which patients…”
Get full text
Journal Article -
13
Lymph-Node-Targeted Immune Activation by Engineered Block Copolymer Amphiphiles–TLR7/8 Agonist Conjugates
Published in Journal of the American Chemical Society (31-10-2018)“…Small molecule immuno-modulators such as agonists of Toll-like receptors (TLRs) are attractive compounds to stimulate innate immune cells toward potent…”
Get full text
Journal Article -
14
Antibodies directed towards neuraminidase restrict influenza virus replication in primary human bronchial epithelial cells
Published in PloS one (31-01-2022)“…Influenza neuraminidase (NA) is implicated in various aspects of the virus replication cycle and therefore is an attractive target for vaccination and…”
Get full text
Journal Article -
15
Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists
Published in Cell death and differentiation (01-01-2014)“…Immunogenic cell death induced by anticancer chemotherapy is characterized by a series of molecular hallmarks that include the exodus of high-mobility group…”
Get full text
Journal Article -
16
The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017
Published in eLife (28-05-2024)“…Human H3N2 influenza viruses are subject to rapid antigenic evolution which translates into frequent updates of the composition of seasonal influenza vaccines…”
Get full text
Journal Article -
17
Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma12
Published in Translational oncology (02-12-2016)“…Therapeutic strategies that act by eliciting and enhancing antitumor immunity have been clinically validated as an effective treatment modality but may benefit…”
Get full text
Journal Article -
18
Antibodies directed towards neuraminidase restrict influenza virus replication in primary human bronchial epithelial cells
Published in PloS one (01-01-2022)“…Influenza neuraminidase (NA) is implicated in various aspects of the virus replication cycle and therefore is an attractive target for vaccination and…”
Get full text
Journal Article